FSN Capital

FSN Capital is a Northern European private equity investment firm focused on control investments in middle-market companies. Founded in 1999/2000 and headquartered in Oslo, the firm advises FSN Capital funds that invest across the Nordics and selected Northern European markets. Its portfolio spans sectors such as technology, services, industrials, green transition, and selected life science-related assets, but FSN Capital itself is not a drug developer or healthcare operating company. In healthcare, its exposure appears to be through portfolio investments such as Adragos Pharma and past investments like Agito Healthcare rather than internal R&D or product pipelines. The firm works with institutional limited partners and operates offices in Oslo, Stockholm, Munich, and Copenhagen.